A Case of Fulminant Meningococcemia: It Is All in the Complement

A Case of Fulminant Meningococcemia: It Is All in the Complement

Eculizumab is a novel monoclonal antibody that inhibits complement-mediated hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH). Complement deficiency is a well-known risk factor for meningococcal infection. We describe a case of a young patient with PNH treated with eculizumab who...

Full description

Bibliographic Details
Main Authors: Kellie L. Hawkins, Mariah Hoffman, Sonia Okuyama, Sarah E. Rowan
Format: Article
Language:English
Published: Hindawi Limited 2017-01-01
Series:Case Reports in Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2017/6093695

Similar Items

Similar Items